Key facts
- Livzym’s last known valuation is $60.0M.
- It has raised $21.0M; the latest was Later Stage VC ($11.0M) in Aug 2024.
- Notable investors include Turkey Development Fund, Türk Telekom Ventures, Danstar Ferment, Development and Investment Bank of Turkiye, Evyap Holding — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Livzym
- ·The full record, as it builds
Funding rounds
No funding rounds for Livzym are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Livzym
Operator of an industrial enzyme company intended to focus on sustainable services in food production in Turkey. The company carries out studies at all stages of production, such as increasing the productivity of the microorganism and the development of the obtained protein in forms suitable for the needs of different sectors, enabling companies to increase efficiency and ensure standardization in every field.
- Sector
- Materials and Resources
- HQ
- Istanbul, Turkey
- Founded
- 2014
- Employees
- 35
- Website
- livzym.com/
- Ownership
- Privately Held (backing)
Livzym doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Livzym shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Livzym in its N-PORT filings yet. We sweep new filings monthly.